Sequent Scientific Limited has informed the Exchange regarding a press release dated May 29, 2025, titled "SeQuent Viyash Merger Receives Stock Exchange Approvals; NCLT Filing Underway.".
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sequent Scientific Limited has shared a press release dated May 29, 2025, updating the market on its proposed merger with Viyash Scientific Limited. The combined entity will operate as SeQuent Viyash. The merger has already received approvals from the stock exchanges. The companies are now in the process of filing the merger with the National Company Law Tribunal (NCLT) for the next round of regulatory clearance. This announcement signals continued progress in the previously announced merger plan between the two pharmaceutical/animal health companies.
Positive near-term signal for shareholders of both Sequent and Viyash as it shows the merger is moving forward on schedule, though the deal is still subject to NCLT and other regulatory approvals before it can be completed.